AMCP Managed Care & Specialty Pharmacy Annual Meeting 2019 Main banner
====================
3/26/2019, 10:00 AM - 11:15 AM
[B1] Managing Access for Gene Therapy: Learnings from an International Perspective

Sophie Schmitz, BA, MA; Kellie Rademacher, PharmD
Room: 6B
====================
3/26/2019, 10:00 AM - 11:15 AM
[F1] Hemophilia Management – Emerging Therapies and Payer Strategies

Edmund J. Pezalla, MD, MPH; Michelle Rice; John Barrett, RPh, MBA
Room: 6F
====================
3/26/2019, 10:00 AM - 11:15 AM
[L1] Federal and State Legislative and Regulatory Update

Elisabeth Brisley, MPH; Mary Jo Carden, RPh, JD; Collin Conway, PharmD
Room: 6C
====================
3/26/2019, 10:00 AM - 11:15 AM
[M1] Leveraging Technology to Optimize Health Outcomes: Results from Real-World Pilots in Patients with Chronic Conditions

Brian MacDonald, PharmD; Mark Santilli, PharmD; Marti Groeneweg, PharmD, BCPS
Room: 6D
====================
3/26/2019, 10:00 AM - 11:15 AM
[R1] Using Rapid Cycle Analytics of Real-World Data to Manage High Risk, High Cost Patients

Sara Eapen, PhD; Saira A. Jan, MS, PharmD; Sebastian Schneeweiss, MD, ScD; Carol L. White, PharmD, BPCS, BCGP, CPHIMS
Room: 6E
====================
3/26/2019, 10:00 AM - 11:15 AM
[SP1] The Pivotal Role of ACOs and IDNs in the Care Delivery System: Impact on Quality and Total Cost of Care
Marylou Buyse, MD, MS; Elizabeth Oyekan, PharmD, FCSHP, CPHQ
Room: 8
====================
3/26/2019, 10:00 AM - 11:15 AM
[V1] Initiation and Implementation of a Value-Based Contract in Medicaid: Challenges and Lessons Learned

Terry Cothran, DPh; Russell L. Knoth, PhD; Hannah Lee-Brown, PharmD
Room: 6A
====================
3/26/2019, 12:45 PM - 2:00 PM
[P1] Specialty Pharmaceuticals in Development

Aimee Tharaldson, PharmD; Joan Siegel, MSPharm
Room: 6A (overflow into 6B)
====================
3/26/2019, 2:30 PM - 3:45 PM
[B2] Brand and Generic Drugs in Development

Jeffrey Casberg, MS, RPh; Leslie Fish, RPh, PharmD; Renee Rizzo Fleming, RPh, MBA
Room: 6C
====================
3/26/2019, 2:30 PM - 3:45 PM
[F2] Mitigating Risk of Inappropriate Opioid Utilization through Formulary Management and Naloxone Co-prescribing

Bonnie C. Greenwood, PharmD, BCPS; Kimberly Lenz, PharmD; Penny Surratt, RN, MBA
Room: 6B
====================
3/26/2019, 2:30 PM - 3:45 PM
[L2] Medicare Formulary Updates Impact

Babette S. Edgar, PharmD, MBA, FAMCP; Greg Miller, RPh; Crescent Moore, PharmD, PhD, BCPS; Jenny Glennon, PharmD, MPH
Room: 6F
====================
3/26/2019, 2:30 PM - 3:45 PM
[R2] Research Podium- Will You Use My Data? Dialogue between Award-Winning Researchers & Formulary Decision-Makers

Steven Champaloux, PhD, MPH; Rita Hui, PharmD, MS; Francis Staskon, PhD, MS; Eric Cannon, PharmD, FAMCP; Tracy McDowd, PharmD; Jay McKnight, PharmD, BCPS; Melissa McCart, PharmD, MS
Room: 6D
====================
3/26/2019, 2:30 PM - 3:45 PM
[V2] The Current State of Value-Based Contracting

James T. Kenney, Jr., RPh, MBA; Jeff Hawes, PharmD
Room: 6A
====================
3/26/2019, 2:30 PM - 5:30 PM
[M2] Medication Therapy Management (MTM) Updates: Transforming Service Delivery through Research and Innovation

Nicole Brandt, PharmD, MBA, BCGP, BCPP, FASCP; IIene Harris, PharmD, PhD; Michael Steinman, MD; Patty A. Kumbera, BSPharm, RPh
Room: 6E
====================
3/26/2019, 4:15 PM - 5:30 PM
[B3] Riding the Biosimilars Wave: The Latest on Utilization, Regulation and Pipeline

Jennifer M. Day, PharmD; Jessica Daw, PharmD, MBA
Room: 6A
====================
3/26/2019, 4:15 PM - 5:30 PM
[F3] Pulmonary Arterial Hypertension and the Managed Care Considerations for Formulary Decision-Making

Eric Cannon, PharmD, FAMCP; Michael J. Cawley, PharmD, FCCM; Brian Mischel, RPh, MBA
Room: 6C
====================
3/26/2019, 4:15 PM - 5:30 PM
[L3] Medicaid Managed Care: CMS Update, Focus on Emerging Standards for Drug Use Review

John M. Coster, BS, MPS, PhD; Paul L. Jeffrey, PharmD; Shellie Keast, PharmD, PhD; Paul L. Jeffrey, PharmD
Room: 6F
====================
3/26/2019, 4:15 PM - 5:30 PM
[R3] Patient-Reported Outcomes and Patient Preferences: Considerations for Coverage Policy Decisions?

Kim A. Caldwell, RPh; James D. Chambers, PhD, MPharm, MSc; Jennifer S. Graff, PharmD; Eleanor M. Perfetto, PhD; Jennifer S. Graff, PharmD
Room: 6B
====================
3/27/2019, 8:30 AM - 9:45 AM
[B4] The Copay Card Conundrum: Examining the Usage, Regulation, and Management of Direct-to-Consumer Funding Programs

Josh Golden; Manjula Jayabalan, PharmD, MBA; Ami Gopalan, PharmD, MBA
Room: 6A
====================
3/27/2019, 8:30 AM - 9:45 AM
[F4] The Road to Pre-Approval Information Exchange: Where Are We Today?

Elisabeth Brisley, MPH; Amy Duhig, PhD; Sheila M. Thomas, PharmD; Elizabeth Sampsel, PharmD, MBA, BCPS
Room: 6B
====================
3/27/2019, 8:30 AM - 9:45 AM
[L4] Drug Pricing Reform Efforts: The Blueprint Turns 1 Year Old

Melissa Andel, MPP; David Wamble, PhD
Room: 6C
====================
3/27/2019, 8:30 AM - 9:45 AM
[M4] Improving Patient Care through Data and Devices

Theresa C. Juday, RPh; Christine Sawicki, RPh, MBA, CLSSMBB; Dawn Delaney-Swain, BSPharm
Room: 6D
====================
3/27/2019, 8:30 AM - 9:45 AM
[V4] Measuring Value of an IDN Specialty Pharmacy Therapy Management Program for Biologics

Tim Affeldt, PharmD; Charles Ruetsch, PhD; Autumn Zuckerman, PharmD, BCPS, AAHIVP, CSP; Kevin Lu, PhD, BSPharm
Room: 6F
====================
3/27/2019, 10:15 AM - 11:30 AM
[H1] AMCP Headline Session: 2018-2019 Pharmaceutical Marketplace Trends
Douglas M. Long, BS, MBA; Susan A. Cantrell, RPh, CAE
Room: 6A (overflow into 6B)
====================
3/27/2019, 2:45 PM - 4:00 PM
[B5] Disruptive Innovation in Health Care: The 2020 Emerging Trends, Entrants, and Drivers of Change

Jorge Font, MPH; Elizabeth Oyekan, PharmD, FCSHP, CPHQ; Gene Reeder, RPh, PhD
Room: 6B
====================
3/27/2019, 2:45 PM - 4:00 PM
[F5] It’s an ART: Formulary and Drug Use Management Strategies for HIV Medications

Desola Davis, PharmD, BCPS, BCACP; Adanna Oragwu, PharmD, BCPS, AAHIVP; Peter Canale
Room: 6D
====================
3/27/2019, 2:45 PM - 4:00 PM
[L5] Evolving 340B Program and its Impact on the Payer and Health Systems Landscape

Linda R. Bolland, PharmD, MBA; Dominic Galante, MD, MS; Isha Bangia, PharmD, MBA
Room: 6F
====================
3/27/2019, 2:45 PM - 4:00 PM
[M5] Using ICER Reports to Supplement Limited Drug Approval Information

Steven Pearson, MD, MSc; Emily G. Tsiao, PharmD; John B. Watkins, PharmD, MPH, BCPS; Jasmine Knight, PharmD, MS
Room: 6A
====================
3/27/2019, 2:45 PM - 4:00 PM
[R5] The Actuarial Influence on Pharmacy Benefits

Karl J. Gregor, PharmD, MS; Drew Kirchner, FSA; Whitney S. Pratt, FSA, CERA, MAAA; Stephen E. Wolff, PharmD, ASA, MAAA
Room: 6C
====================
3/27/2019, 4:30 PM - 5:30 PM
[L6] The Current Status of Safe Harbor Protection for Rebates: Is the End Near?
Ross D. Margulies, JD, MPH; Jane Guo, PharmD, MBA
Room: 6C
====================
3/27/2019, 4:30 PM - 5:30 PM
[RT1] Best Practices in Mitigating Risk of Inappropriate Opioid Utilization

Bonnie C. Greenwood, PharmD, BCPS; Kimberly Lenz, PharmD
Room: 5A
====================
3/27/2019, 4:30 PM - 5:30 PM
[RT2] Sharing Ideas on Pre-Approval Information Exchange Implementation

Elisabeth Brisley, MPH; Amy Duhig, PhD; Sheila M. Thomas, PharmD
Room: 5B
====================
3/27/2019, 4:30 PM - 5:30 PM
[RT3] Real-World Insights into Payers’ Strategies with the 340B Drug Discount Program

Linda R. Bolland, PharmD, MBA; Dominic Galante, MD, MS
Room: 4
====================
3/27/2019, 4:30 PM - 5:30 PM
[RT4] Maximizing the Value of Actuarial Data When Managing the Pharmacy Benefit

Karl J. Gregor, PharmD, MS; Drew Kirchner, FSA; Whitney S. Pratt, FSA, CERA, MAAA
Room: 3
====================
3/28/2019, 8:00 AM - 9:15 AM
[F7] Generic Trend Management: Decreasing High Cost Generic Spend by Shifting Utilization

Sara Carruth, PharmD; Alan Lukazewski, RPh, CDE, CGP; Craig S. Stern, RPh, PharmD, MBA
Room: 6B
====================
3/28/2019, 8:00 AM - 9:15 AM
[M7] Strategies for Staying Ahead of Specialty Drug Trends: Focus on the Medical Pharmacy Benefit

Eric McKinley, PharmD; Carly Rodriguez, PharmD; Grant Knowles, PharmD, CSP
Room: 6C
====================
3/28/2019, 8:00 AM - 9:15 AM
[V7] Regulation to Outcomes: The Impact of Real-Time Prescription Benefit Checks

Jacqueline Hager, BS; Roger G. Pinsonneault, RPh; Louis J. Fayant, MBA
Room: 6A
====================
3/28/2019, 11:15 AM - 12:30 PM
[B8] Budgeting for the 2021 Specialty Drug Spend

Susan Trieu, PharmD; Lisa Valaika
Room: 6A
====================
3/28/2019, 11:15 AM - 12:30 PM
[V8] Aligning Values: Creating Awareness and a Roadmap for Mutual Success

Donald Carroll, MHA, RPh; Kathleen Shoemaker, PharmD, MBA, CPHIMS
Room: 6B